© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Highlighted Videos
Episode 62: The Future of Pharma’s Supply Chain
August 06, 2020
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.
Success Factors for Orphan Drug Development
August 04, 2020
When approached correctly, drug development in the rare disease space can be quite successful – especially when powerhouses across the industry join forces and leverage the power of data to help drive potential treatment options.
What Makes for a Great Leader in Pharma, and How to Hire One
August 04, 2020
A look into the traits that hiring managers of pharma companies should be searching for when hiring for a leadership role.
Unlock Real World Evidence with Pragmatic Data Governance and Quality Practices
August 04, 2020
How companies are leveraging Real Word Evidence to evaluate therapies under real world conditions in a broader population at a lower cost than using Randomized Clinical Trials.
How COVID-19 Has Affected Launches of New Oncology Therapies in the U.S.
August 04, 2020
Several months into the COVID-19 pandemic, this article takes a look back at how the launches of new oncology therapies have been impacted.
Debate Accelerates Over Who Gets COVID Vaccine First
August 03, 2020
As biopharma companies and research institutes advance the development of promising vaccines against COVID-19, policy makers and health officials have intensified deliberations on strategies for ensuring fair and equitable distribution of anticipated preventives.
EU Medical Device Supply Chains and Trade Agreements: The COVID-19 Response
August 02, 2020
Andrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.
IQVIA Launches New OCE Optimizer
July 30, 2020
IQVIA has announced the launch of OCE Optimizer, which will look to help life sciences companies reach HCPs more effectively.
Support Your Clinical and Economic Value Proposition with Real World Data: Data and technology-enabled evidence generation
July 30, 2020
Healthcare decision-makers have become increasingly aware of the need to utilize real world data (RWD) to better-understand treatment patterns, disease burden, and the impact of interventions from both a clinical and cost perspective. Join IQVIA to learn more about the pivotal role RWD now plays in informing decisions about access and reimbursement, drug safety, and comparative effectiveness. Live: Thursday, Aug. 20, 2020 at 2pm EDT On demand available after airing until Aug. 20, 2021.
Is Your Real World Data Credible? Tips to identify and evaluate the right RWD for your organization
July 28, 2020
Sponsored Content
The pool of available Real World Data sources for Pharma is both impressive and expanding continuously, but how do you determine the credibility of those sources? Join us as we share tools and strategies to identify the right data source for your organization, and improve both the quality and impact of your Real World Evidence studies. Live: Tuesday, Jul. 28, 2020 at 11am EDT On demand available after airing until Jul. 28, 2021 Register free
Titan Pharmaceuticals and Indegene: Partnering for the Post-COVID Landscape
July 27, 2020
Titan Pharmaceuticals' Sunil Bhonsle and Indegene's Jamie Peck talk about their new partnership and how it will move forward in the post-COVID environment.
HCPs & Virtual Meetings: Taking the Learnings Forward
July 27, 2020
Nate Wible and Dan Donovan evaluate the shift from in-person to virtual HCP meetings and look toward the future of this model.
Stakeholders Seek Increased User Fee Support for Biologics
July 24, 2020
Patient advocates, research experts, and industry are calling for more user fee revenues to support CBER programs to advance innovative therapies.
Clearing the Hurdles to a Career in Venture Capital
July 23, 2020
Dr. Geeta Vemuri, founder of biopharma investment firm Agent Capital, talks about sustaining a career in the venture capital sector.
Episode 61: Preparing for Virtual High-Stakes Meetings
July 23, 2020
Pharmaceutical Executive
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.
Will COVID-19 Usher in a New Era in Pharma Marketing?
July 22, 2020
Pharmaceutical Executive
Embracing expanded digital models key to future ROI.
Strategic Realignment for a Better Future
July 21, 2020
In adjusting to the long-term side-effects of the coronavirus pandemic, pharma companies will need to focus on change in three areas. Ben van der Schaaf and Aurelien Guichard report.
Launching during Lockdown
July 21, 2020
Immunomedics’ CFO/CBO Usama Malik discusses how a lot of good planning and a little good fortune helped the company to achieve its “virtual launch” amid the coronavirus crisis.
Drug Pricing Back in the Spotlight
July 21, 2020
Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?
Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience Goals
July 20, 2020
Learn how breakthrough patient experience strategies can help achieve your study goals in this upcoming webcast. Lead by renowned neuroscientist and behavioral economist Dr. Paul Glimcher, it’s the one webcast this year your team can’t afford to miss. Live: Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until May 19, 2021.
Will FDA Inspections Ever Be the Same?
July 20, 2020
FDA's plans to resume inspections of some US regulated facilities this week are not clear on which sites will be visited and what alternative oversight strategies will apply where on-site inspections are difficult.
COVID-19: Expanding Remote Patient Services during Lockdown
July 20, 2020
Stephanie Hill looks at the efforts made by patient solutions providers in the UK to build and support services outside the hospital environment during the pandemic.
Patient Information Labeling and COVID-19
July 20, 2020
In recent months, many pharma businesses have pivoted to entirely new product lines against a backdrop of unprecedented disruption to the supply chain. Gurdip Singh provide pointers to ensure companies are ready to adapt to change.
Are You Ready for the Telemedicine Revolution?
July 19, 2020
A new patient journey is emerging. Gilda Sala, Trista Bridges, and Rune Soelvsteen offer easy steps to future-proof your company’s approach.
Discussing the Use of Virtual Meeting Technology with Sales VP, Chris Deluzio
July 17, 2020
Following his presentation at Veeva Systems’ Commercial & Medical Summit, Pharmaceutical Executive got a chance to discuss virtual meeting technology and pharma sales with Senior VP, Sales and Commercial Operations, Biohaven, Chris Deluzio.
Expedite Regulated Documents in the Era of COVID-19: From Development to Trials and Manufacturing
July 15, 2020
Sponsored Content
Technology is more critical than ever to help you keep your clinical trials on track during the era of COVID-19. Gain best practices about how to empower your remote workforce, get critical regulated documents electronically signed compliantly, and to create a safe and flexible remote patient-centric experience. Live: Wednesday, Jul. 15, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Jul. 15, 2021. Register free
MJH Life Sciences' State of the Physician Survey: Financial Impact of COVID-19
July 13, 2020
In the second of MJH Life Sciences' State of the Physician reports, over 1,600 respondents weighed in on how they have been affected financially by COVID-19 and what it means for them moving forward.